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Functional shift with maintained 
regenerative potential following 
portal vein ligation
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László Homolya  5 & Attila Szijártó1
Selective portal vein ligation (PVL) allows the two-stage surgical resection of primarily unresectable 
liver tumours by generating the atrophy and hypertrophy of portally ligated (LL) and non-ligated 
lobes (NLL), respectively. To evaluate critically important underlying functional alterations, present 
study characterised in vitro and vivo liver function in male Wistar rats (n = 106; 210–250 g) before, and 
24/48/72/168/336 h after PVL. Lobe weights and volumes by magnetic resonance imaging confirmed 
the atrophy-hypertrophy complex. Proper expression and localization of key liver transporters (Ntcp, 
Bsep) and tight junction protein ZO-1 in isolated hepatocytes demonstrated constantly present viable 
and well-polarised cells in both lobes. In vitro taurocholate and bilirubin transport, as well as in vivo 
immunohistochemical Ntcp and Mrp2 expressions were bilaterally temporarily diminished, whereas 
LL and NLL structural acinar changes were divergent. In vivo bile and bilirubin-glucuronide excretion 
mirrored macroscopic changes, whereas serum bilirubin levels remained unaffected. In vivo functional 
imaging (indocyanine-green clearance test; 99mTc-mebrofenin hepatobiliary scintigraphy; confocal 
laser endomicroscopy) indicated transitionally reduced global liver uptake and -excretion. While LL 
functional involution was permanent, NLL uptake and excretory functions recovered excessively. 
Following PVL, functioning cells remain even in LL. Despite extensive bilateral morpho-functional 
changes, NLL functional increment restores temporary declined transport functions, emphasising liver 
functional assessment.
With a worldwide ranking of sixth in incidence and third in cancer-related deaths, liver malignancies repre-
sent a chief challenge for liver surgery1. Doubtlessly, the sole curative treatment is complete tumour elimination, 
preferably by surgical resection2,3. Meanwhile, much different clinical management is required in patients with 
large liver tumours, requiring extensive resections, sparing only an undersized ‘future liver remnant’ (FLR), and 
thereby risking the development of liver failure. In such cases, the ‘resection of unresectable’ may still be realised 
in two stages and an intercalated waiting period through preoperative FLR enlargement protocols2. A key solution 
for overcoming this problem is portal vein occlusion (PVO) procedures4,5. PVO is performed by either the liga-
tion (PVL) or embolization (PVE) of selected portal vein tributaries, leading to the atrophy of portally deprived 
lobes and the parallel compensatory hypertrophy of portally perfused lobes; a special form of liver regeneration 
(LR), the latter being nature’s enigmatic phenomenon visionarily foretold by the Promethean legend6–8. LR has 
thoroughly been investigated by a number of studies utilising partial hepatectomy (PH)9. Whilst physiological 
drives and features of PVO- and PH-induced LR are matching, PVO has to be regarded as a delicately unique 
form of LR. Firstly, two directly opposite adaptive physiological processes (atrophy-hypertrophy complex) are 
maintained strictly separated within the liver. Secondarily, as opposed to the simple setting of PH of instant liver 
loss and hypertrophy as the exclusive adaptive response, the twin processes of PVO are closely co-regulated, 
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since the development of hypertrophy is strictly bound to concomitant atrophy6. Therefore, PVO techniques 
exploit the different adaptive mechanisms of portally occluded- and non-occluded liver lobes. The latter undergo 
a peculiar regenerative process, presenting a volume increase, presumably accounting for the lost capacities of 
lobes devoid of portal blood. However, beyond well-documented morphological alterations, there is scarce evi-
dence on how PVO procedures affect cellular and organ-wide hepatic functions, despite their paramount basic 
research and clinical significance10. Although a ‘full-scale’ hepatic functional quantification remains a platonic 
idea, the analysis of organic anion (bilirubin, bile salts, etc.) transport may be fairly representative, judging from 
its central physiological and clinical relevance11. On one hand, this may be well performed in in vitro cell cultures, 
which provide basic information regarding the specific characteristics of the involved transport routes. However, 
culturing intrinsically discards dead cells, limiting data interpretation in living systems. Therefore, in vivo meas-
urements are essential for the evaluation of alterations in liver functions. Global tests, such as the clinically widely 
applied indocyanine-green (ICG) clearance test, only measure total liver function and are insufficient during PVO 
procedures, when liver function is inhomogeneously distributed between the atrophic and hypertrophic lobes. 
However, recent state-of-the-art nuclear imaging technologies, such as hepatobiliary scintigraphy (HBS) and 
single photon emission tomography (SPECT) using liver-specific radiopharmaceuticals (like 99mTc-mebrofenin 
[99mTc-2,4,6-trimethyl-3-bromo iminodiacetic acid]) enable sophisticated functional assessment of individual 
liver regions including the critically important FLR12,13. Furthermore, liver function may also be visualised by 
the novel fluorescence-based method, ‘confocal laser endomicroscopy’ (CLE)14. Conclusively, our goal was the 
temporal assessment of morpho-functional aspects of PVO-induced LR with a special focus on organic anion 
transport, involving in vitro, as well as multimodal in vivo analyses. Additionally, we wished to clarify the role 
that cellular junction proteins and organic anion transporters play in the regenerative potential of ligated lobes 
undergoing involution.
Results
PVL induces both atrophy and hypertrophy with unchanged total liver weight. As the cor-
nerstone for further analysis, macroscopic parameters of regeneration were initially determined (Fig. 1). The 
weight of the ligated lobes (LL) significantly decreased (0.41 ± 0.17% vs. 3.41 ± 0.14%), whereas non-ligated lobe 
(NLL) weights significantly increased (3.04 ± 0.1% vs. 1.09 ± 0.1%) as compared to control. Total liver lobe weight 
remained essentially unchanged. In vivo liver lobe volumes following PVL were also assessed in the mebrofenin 
group by serial postoperative MRI scans. Accordingly, 3D-reconstructions of liver lobe volumes showed close 
correlation with the weight of both the LL (r = 0.976; p = 0.001) and NLL (r = 0.96; p = 0.002). In general, PVL 
has proven viable in mediating the established atrophy-hypertrophy complex of the liver.
Hepatocytes from both lobes unequivocally maintain polarity and bile duct formation capac-
ity, while gradually recovering from a temporary functional decrease. For the basic evaluation of 
morphological and functional attributes of cells constituting the LL and NLL, corresponding cell cultures were 
created. A substantial number of viable hepatocytes (at least 50 million) could be isolated at all time points from 
both the NLL and LL. Immunofluorescence (IF) staining for zonula occludens-1 (ZO-1), sodium-taurocholate 
cotransporting polypeptide (Ntcp), and bile salt export pump (Bsep) demonstrates that isolated cells from both 
liver regions are able to generate polarised cultures with normal morphology, forming bile canaliculi, expressing 
and properly localising the key liver transporters (see Fig. 2 for representative images, IF for all time point are 
shown in Supplementary Figures 1, 2). To assess in vitro function beyond morphology, taurocholate and bili-
rubin transport measurements were performed (Fig. 3). Taurocholate (TC) uptake and canalicular efflux were 
significantly deteriorated at 48–72 h in both lobes. Likewise, the uptake and canalicular excretion of bilirubin 
were also significantly reduced at 48 h in LL. Considering the bilirubin transport of NLL, a very similar, though 
non-significant tendency was detected. However, intracellular load of both TC and bilirubin remained constant 
throughout the observation period. Results of the in vitro analysis confirmed the constant presence of viable and 
transporter-expressing cells in both the LL and NLL, as well as a transient, but marked reduction of TC and to a 
lesser extent bilirubin transport in both lobes without significant intracellular accumulation.
Temporary bilobar reduction of transporter expression with necroapoptotic patches in ligated 
lobes as well as divergent interlobar acinar changes. IF staining carried out on frozen sections of 
the LL and NLL of control rats demonstrated normal acinar outlines with proper canalicular and basolateral 
localisation of canalicular multispecific organic transporter (Mrp2) and Ntcp, respectively (Fig. 4). 72 h after 
PVL, the LL displayed large patches with abrogated staining for Mrp2 or Ntcp, likely corresponding to necroap-
optotic lesions. Meanwhile NLL sections at 72 h lacked any regional differences; however, expression level of both 
proteins was generally reduced. After 336 h, transporter expression was restored in both lobes. However, acinar 
structures became divergent; LL acini were markedly shrunk, while NLL acini became expanded (representative 
hematoxylin-eosin stained sections are shown on Supplementary Figure 3).
Lobe performance rearrangement maintains bilirubin excretion and keeps serum bilirubine in 
control. To assess in vivo bile excretion, selective biliary drainage of the LL and NLL was performed (Fig. 5). 
The bile output was progressively decreased, and oppositely, significantly increased in the LL and NLL, respec-
tively, with unchanged overall bile output. Total biliary BG contents altered in parallel with bile production. BG 
output showed a bilateral response in accordance with atrophy-hypertrophy. There were no significant changes 
in serum levels of either unconjugated bilirubin (UCB), conjugated bilirubin (BG), or total bilirubin in any time 
points, despite their tendentious rise. In line with this, both the serum and biliary UCB to total bilirubin ratios were 
unchanged. Altogether, both bile and BG excretion indicated bilateral responses in basic hepatic function, involving 
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the functional gain of NLL and the continuous decay in LL function. Meanwhile serum- and biliary levels of bili-
rubin fractions were unchanged, implying that elimination of endogenous substrates is unaffected following PVL.
Transient suppression of global hepatic function with the lag of excretion. To assess in vivo 
global hepatic functions dynamic liver function tests were performed (Fig. 6). The ICG-clearance test exhibited 
a marked drop between 24–72 h (diminished plasma disappearance rate [PDR], 5.8-fold increased retention at 
15 minutes [RT15]), which rapidly normalised by 168 h. These results were echoed by the hepatobiliary scintigra-
phy (HBS) test. Blood half-life (B1/2), reflecting global hepatic uptake function, exhibited a very similar pattern to 
RT15, as significantly increased at 48–72 h, and rapidly normalised thereafter. First duodenal appearance (DSTART), 
reporting on global hepatic excretory function showed similar changes; noteworthy though, that it was signifi-
cantly prolonged at 168 h, and was not completely restored by 336 h. Taken together, contrary to the excretion of 
endogenous organic anions such as bilirubin, the elimination of exogenous ligands suffered a temporary reduc-
tion, indicating a transient suppression in global liver function.
Compensatory increase of xenobiotic excretion in the non-ligated lobes complements perma-
nently deteriorated ligated lobe functions. Nuclear imaging techniques enable sophisticated evalua-
tion of regional liver function. Therefore, a planar 99mTc-mebrofenin HBS test was performed to assess hepatic 
Figure 1. Macroscopic changes. Portal vein ligation (PVL) mediated the progressive atrophy and hypertrophy 
of ligated- and non-ligated lobes, respectively, which was reflected on all (frontal, sagittal, and horizontal) 
sections as well as three-dimensional (3D) reconstructions of serial magnetic resonance imaging scans (a). 
Quantification with liver lobe volumetry (bw: body weight) and weighing of liver lobes collected in parallel 
also confirmed the atrophy-hypertrophy complex, whereas essentially unchanged parameters of the total 
liver marked the balanced nature of the process (b,c). Statistical analysis was performed with analysis of 
variance (ANOVA) with Bonferroni’s post hoc test to correct for multiple comparisons. Results are given as 
means ± standard deviation, with (a,b) representing n = 9 and (C) representing n = 5 animals per time points.  
‘*’, ‘&’ and ‘σ’ indicate p < at least 0.05 for actual versus control values of ligated lobes, non-ligated lobes or total 
liver, respectively. ‘#’ indicates p < at least 0.05 ligated lobes versus contemporary non-ligated lobes.
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function separately in the LL and NLL (Fig. 7). As illustrated by representative HBS registries, the peaks in both 
LL and NLL decreased and widened after PVL. However, by 336 h, the kinetics of drug elimination normalised in 
the NLL, whereas flattened in LL resulting in a solid gap between their curves. Accordingly, regional function was 
well-reflected in relative ratios of the LL and NLL peak counts (PC) to the corresponding blood count. A transi-
tional regional functional depression was observed in both lobes at 24–72 h, which was gradually restored in the 
NLL at 336 h, but remained diminished in LL, resulting in a significant difference between LL and NLL regional 
functions after 48 h. To further elaborate this, we selectively measured NLL regional function by CLE, which 
allowed the monitoring of ICG transport in a particular liver region. Time of maximum (TMAX) (~uptake) and 
half-life (T1/2) (~excretion) values, derived from intensity curves, confirmed a transitional drop of NLL regional 
uptake and excretory function at 24–72 h, after which both parameters gradually reached preoperative levels. 
Altogether, our observations indicate a transient, bilateral deterioration of regional function, followed by the 
compensatory functional gain of the NLL resulting in a massive divergence of liver function.
Discussion
Portal vein ligation-induced liver regeneration remains an essential element of arsenal in liver surgery for the 
curative two-stage resection of primarily unresectable liver tumours. Therein, hepatic functional aspects of this 
procedure are of great significance. Hence, the present experimental analyses dedicated prime interest to the 
temporal alterations of both global and regional liver function by ‘benchmarking’ cellular aspects with culturing 
in vitro and assessing hepatic function with relevant modern imaging technologies in vivo. Remarkably, despite 
the absence of portal inflow and its special blood-borne constituents (nutrients, hormones, and growth factors, 
etc.), and the severe morphological consequences of atrophy, such as necroapoptosis and structural remodeling, 
we found evidence for the presence of viable, transporter-expressing and functioning hepatocytes in the LL even 
as far as 336 h after PVL, implying the plausibility of process reversibility. We have further confirmed a transient 
Figure 2. In vitro immunofluorescence. Representative images of cultured hepatocytes isolated from liver of 
control rats, as well as from the ligated and non-ligated lobes of rats 72 h and 336 h after portal vein ligation 
are shown. The samples were immunostained for the sodium-taurocholate cotransporting polypeptide 
(Ntcp) [labelled as red] and zonula occludens-1 (ZO-1) protein [labelled as green] (a–c), as well as for the bile 
salt export pump (Bsep) [labelled as green] (d–f). Cells, regardless of lobar or temporal origin, maintained 
their ability of generating viable cultures, forming bile canaliculi correctly sealed with ZO-1, and properly 
expressing the essential hepatic transporters, Bsep and Ntcp. Cell nuclei stained with DAPI (4′,6-diamidino-2-
phenylindole) are show in grey scale. Representative markings indicate ZO-1 positive intercellular connections 
(asterisks), membrane expression of Ntcp (arrowheads) (a–c), as well as specific bile canaliculi (triangles) 
(d–f). White bars represent 25 µm. The whole sets of pictures from all time points are available online in 
Supplementary Information (Supplementary Figures 1, 2).
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drop in global hepatic function, followed by a relatively rapid recovery. In the background of re-establishment, 
a clear divergence of in vivo regional hepatic function was found, with progressive involution of the LL and the 
massive functional gain of the NLL, leading to inhomogeneous functional distribution between liver lobes and 
a shift in regional function towards the NLL. Finally, the present study is the first known application of confocal 
laser endomicroscopy for the analysis of segmental hepatic function, confirming the temporary deterioration of 
NLL uptake and excretory functions.
Figure 3. In vitro transport analysis. The specific taurocholate (a,b,e) and bilirubin (c,d,f) transport of 
hepatocytes 72 h in cultures isolated from ligated- and non-ligated liver lobes were measured in vitro. The 
uptake and excretion of both substances were uniformly reduced at 48–72 h in both lobes, normalising 
thereafter by 168–336 h. While changes in terms of ligated lobes were significant, the bilirubin transport of non-
ligated lobes was only tendentiously decreased, implying a more preserved state (a–d). As a result of adaptive 
patterns, the intracellular compartment of both compounds remained unchanged (e,f). PVL: portal vein 
ligation. Statistical analysis was performed with analysis of variance (ANOVA) with Bonferroni’s post hoc test 
to correct for multiple comparisons. Results are given as means ± standard deviation, with n = 5 animals per 
time points. ‘*’ and ‘&’ indicate significant differences in the transport rates of ligated lobes and non-ligated lobes, 
respectively, as compared to control values (p < 0.05).
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Perplexingly, the origination of all these widespread changes may eventually be traced to PVL. The mere 
ligation of the portal vein branch is ultimately responsible for overwhelming alterations of both hepatic structure 
and physiology. Hemodynamically, liver lobes become separate after PVL, with a halved total-, and an increased 
Figure 4. Morphology of ex vivo liver sections. To characterise acinar structure and transporter expression after 
portal vein ligation, immunofluorescence staining for sodium-taurocholate cotransporting polypeptide (Ntcp) 
[labelled as green] and canalicular multispecific organic transporter (Mrp2) [labelled as red] were performed 
on sections of snap frozen liver specimens excised from ligated lobes (a–c) and non-ligated lobes (d–f). As 
compared to control (a,d), 72 h sections of both lobes showed lower transporter expression with void patches 
in ligated lobes (b). Transporter expressions at 336 h were bilaterally re-established; however, diverging acinar 
changes were observed as shrunk and enlarged liver acini were seen in ligated (c) and non-ligated lobes (f), 
respectively. Dashed line markings represent arbitrary acinar borders. White bars represent 100 µm.
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fraction of arterial blood flow (hepatic artery buffer response - HABR: increase in arterial flow due to the decrease 
in portal flow leading to a decreased ‘washout’ of vasodilatative adenosine) through the LL, meanwhile, a hyper-
perfusion (~230%) of mainly (>97%) portal blood flow with reverse HABR takes place in the NLL6. Nevertheless, 
splanchnic circulatory redistribution is inherently accompanied by a reduced oxygen supply of both hepatic lobes, 
as well as an increased delivery of portal constituents to the NLL such as nutritional factors, recirculating bile 
acids, hormones, and growth factors, while these portal blood-borne factors are dramatically less accessible for 
the LL6. As a result of these complex hemodynamic, hypoxic, and humoral changes, liver regeneration is triggered 
in the NLL, while atrophy with necroapoptotic cell death, acinar atrophy, and pseudocapillarisation takes place 
in the LL.
In the present study, the initial assessment of macroscopic parameters served as a proof of concept and 
model reliability. To no contention of our previous results and literature data, liver lobe weight and volume both 
confirmed the development of LL atrophy and NLL hypertrophy. Beyond this, we have earlier found extensive 
necroapoptotic lesions in the LL and an intensive rise in NLL mitotic activity15,16. Total liver weight remained 
unchanged, indicating the balanced nature of the process. Having verified model reproducibility, next we 
embarked to explore functional aspects of PVL-induced LR. With respect to the inexplicable complexity of ‘liver 
function’ an all-around functional assessment remains an idealistic, yet impossible approach. Therefore, we eval-
uated liver organic anion transport (involving Ntcp, Oatp, and Abc transporters), for it fulfils a critical role in 
hepatic detoxification pertaining to both endogenous (bilirubin metabolites and bile acids) and a wide range of 
exogenous substrates (drugs and other xenobiotics)11. The latter further underlines its key importance, for on one 
hand, transporter activity disturbances massively alter clinically administered drug pharmacokinetics. On the 
other hand, several clinically used liver function tests (ICG-clearance, HBS, functional MRI) are methodically 
and pharmacokinetically based on specific organic anion transport routes11,17. The current study initially focused 
on the elementary, cellular aspects of PVL-induced functional changes in vitro by cell culturing. Hepatocytes with 
Figure 5. Bile excretion and bilirubin homeostasis. Acquired via selective biliary drainage, bile (a) and 
bilirubin glucuronide (BG) (b) excretion mirrored the atrophy-hypertrophy complex induced by portal vein 
ligation (PVL), with progressively decreasing output of ligated lobes and the definite gain-of-function of non-
ligated lobes, while total excretion remained unchanged. Serum bilirubin levels (c), as well as the serum and 
biliary fraction of unconjugated bilirubin (UCB) to total bilirubin (d) were unaffected. Statistical analysis 
was performed with analysis of variance (ANOVA) with Bonferroni’s post hoc test to correct for multiple 
comparisons. Results are given as means ± standard deviation, with n = 5 animals per time points. ‘*’ and ‘&’ 
indicate significant differences in the values of ligated lobes and non-ligated lobes, respectively, as compared to 
control values (p < 0.05).
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Figure 6. Global liver function. Total in vivo hepatic function after portal vein ligation (PVL) was evaluated by 
the indocyanine-green (ICG) clearance test (a,b) and planar 99mTc-mebrofenin hepatobiliary scintigraphy (HBS) 
(c–f). A significant temporary reduction in global function at 48 h was reflected in decreased plasma disappearance 
rate (PDR) of ICG (A), leading to increased ICG retention in the bloodstream at 15 minutes (RT15) (b). Planar 
99mTc-mebrofenin HBS was recorded in three dynamic phases illustrated on section c, where the first (left-to-right) 
snapshot corresponds to tracer injection and rapid distribution, the second confirms localisation to the liver, 
whereas the third exhibits hepatic excretion and the intestinal phase. Different organs are marked with pointing 
arrowheads as follows: rightward - heart, upward - kidneys, leftward - abdominal aorta, downward - liver, and 
oblique - intestine(s) (c). Evaluation was performed by region-of-interest allocation to heart, duodenum, as 
well as ligated and non-ligated lobes, producing intensity curves with different characteristics on HBS registries, 
including exponential decay for the bloodstream, and a sigmoid saturation-like curve for the duodenum. Ligated 
and non-ligated lobe functions were judged by their peak counts (PC), as well as derived ratios (d). Similar to the 
ICG clearance test, global hepatic uptake (B1/2) and excretion (DSTART) parameters also indicated a transitional 
reduction in global liver function at 48–72 h. In contrast to global hepatic uptake, the normalisation of global 
hepatic excretion lagged until 336 h (e,f). Statistical analysis was performed with analysis of variance (ANOVA) 
with Bonferroni’s post hoc test to correct for multiple comparisons. Results are given as means ± standard 
deviation, with (a,b) representing n = 7 and (c–f) representing n = 9 animals per time points. ‘*’/‘**’/‘***’ indicate 
significant differences as compared to control values (p < 0.05/0.01/0.001, respectively).
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overall cell viability of >90%, with a sustained potential for generating viable cultures with adequate cell junction 
and bile canaliculus formation, as well as proper expression and localisation of Ntcp and Bsep transporters could 
be isolated from both lobes at any time points. Furthermore, the quantitative transport function of cell cultures 
from either liver segments were measured in vitro. The canalicular efflux of taurocholate, mediated by Bsep in 
Figure 7. Regional liver function. Planar 99mTc-mebrofenin hepatobiliary scintigraphy (HBS) (a–d) and 
confocal laser endomicroscopy (CLE) (e,f) were utilised to assess regional hepatic function of both ligated 
lobes (LL) and non-ligated lobes (NLL) after portal vein ligation (PVL). As compared to control conditions 
(a), 99mTc-mebrofenin HBS registries at 72 h showed diminished regional function reflected in peak reduction 
and widening (b). However, according to 336 h registries, these changes were reversed in the NLL, but further 
deteriorated in the LL (c). Hence, the divergence of lobar functional output was confirmed by a progressively 
developing gap between NLL and LL curves, attributable to a solid functional gain of the NLL, as reflected by 
the ratio of lobar peak counts (PC) per corresponding blood counts (d). CLE intensity curves of indocyanine-
green transport revealed altered curves at different time points of liver regeneration (e). Following curve 
analysis, the transitional elevation and subsequent normalisation of derived parameters (TMAX, T1/2) proved 
a transient suppression and rapid regeneration of NLL uptake and excretory functions (f). Statistical analysis 
was performed with analysis of variance (ANOVA) with Bonferroni’s post hoc test to correct for multiple 
comparisons. Results are given as means ± standard deviation, with (a–d) representing n = 9 and (e,f) 
representing n = 5 animals per time points. ‘*’/‘**’/‘***’and ‘&’/‘&&’/‘&&&’ indicate significant differences in the ligated 
lobes or non-ligated lobes, respectively, as compared to control values, whereas ‘#’/‘##’/‘###’ indicate significant 
differences between the ligated and non-ligated lobes (p < 0.05/0.01/0.001).
www.nature.com/scientificreports/
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an ATP-dependent manner, was transitionally depressed at 48–72 h in both lobes, which may be explained by 
cellular energetic imbalance. While lowered energy status in the LL might be due to decreased oxygen delivery 
secondary to the drastically reduced total blood flow, in the NLL, it is presumably a consequence of the intense 
proliferation, peaking around 48 h, which idea is supported by our previous findings15, as well as other reports, 
stating a decreased cellular energy charge in the initial phase of LR following PVL18,19. TC uptake showed similar 
transitional depression. Besides energetic issues, an adaptive response preventing intracellular bile acid overload 
toxicity is also suspected, since following PVL, all intestinally reabsorbed, portal-borne TC is directed towards 
the NLL20. Accordingly, TC uptake decreased while basolateral efflux tendentiously increased (see Supplementary 
Figure 5), resulting in unchanged intracellular TC levels. A similar adaptive response was previously reported 
during PH-induced LR21. Pattern of changes in bilirubin transport was similar; however, alterations remained 
non-significant, implying a more tightly regulated hepatic bilirubin transport. A possible explanation might lie in 
the higher variability, redundancy and lower transporter-dependency of bilirubin uptake transport as compared 
to TC transport. Oatp1a/1b knock-out mice models revealed that besides Oatp1a1, -1a4, and -1b2, bilirubin and 
UCB may also enter hepatocytes by bromosulfophthalein/bilirubin-binding protein-mediated transport and pas-
sive basolateral diffusion, respectively. Moreover, loss-of-function of either transporter may be well compensated. 
Meanwhile, bile acids are predominantly imported by Oatp1a, -1b2, and Ntcp, and functional deterioration can-
not be fully compensated by the other transporters17,22. Altogether, in vitro results imply a preserved functional 
status, which seems well-established in terms of the NLL. However, it is of paramount interest, that even after 
336 h, the LL still contains viable and functional cells. Regarding this, the question arises, whether these cells 
were capable of re-developing hepatic acinar structure and specific function, if allowed portal reperfusion with 
the cessation of occlusion. Until recently, adaptive changes after PVO were consensually regarded as irreversible 
with clear endpoints of atrophy and hypertrophy. However, the utilisation of absorbable embolization materials 
led to the discovery of reversible PVO. The reversibility of occlusion and subsequent macroscopic changes have 
been reported23,24. Our findings significantly add to the cellular background by testifying that in idealised cir-
cumstances (cultures), hepatocytes residing in the atrophic LL are not only capable of forming viable cultures, 
but also express hepatocyte-specific transporters, whose functionality is demonstrated by in vitro organic anion 
transport. These open new insights of LR by confirming the maintained viability of hepatocytes in pathophysio-
logical conditions, capable of stimulation for re-establishment of liver structure and function. The latter may have 
key significance regarding both basic research and clinical fields of regenerative and transplantation medicine.
Since the applicability of cell culturing techniques are limited by the fact that viable cells are selectively isolated 
and investigated, these in vitro approaches cannot assess the degree and functional consequences of cell death, 
which is unambiguously present following PVL. Therefore, in vitro experiments were complemented with ex vivo 
and in vivo methods to assess conditions in living organisms. To investigate morphology and zonal transporter 
expression, Ntcp and Mrp2 IF were performed on snap-frozen liver sections. Accordingly, 72 h sections of the LL 
revealed void patches, short of transporters, likely reflecting necroapoptotic regions, absent from contemporary 
NLL sections, displaying generally lower expression of both transporters. Meanwhile at 336 h, LL and NLL liver 
acini were shrunk and enlarged, respectively, with no void patches. Alterations in LL and NLL liver acini mor-
phology are supported by representative hematoxylin-eosin stains (see Supplementary Figure 3) and our earlier 
liver resin perfusion findings15. Overall, a temporarily lower transporter expression was confirmed in both lobes, 
which may contribute to the contemporary suppression of transport functions.
Afterwards, we focused on in vivo function. The proximal element was the evaluation of bile- and biliru-
bin excretion through selective biliary drainage for it well reflects basic aspects of hepatic function due to its 
high energy consumption. Both bile- and conjugated bilirubin output mirrored changes in liver lobe weights, 
inasmuch as bile- and BG production of the LL was progressively deteriorated, while a massive NLL output 
gain was observed, with preserved overall bile- and BG excretion. Meanwhile, serum levels of UCB, BG, and 
total bilirubin; as well as the fraction of UCB to total bilirubin in serum and bile were unchanged, corroborat-
ing with in vitro results, indicating a maintained bilirubin transport function of the liver. The preserved excre-
tion of the endogenous, yet toxic agent bilirubin might be a highly important defensive mechanism. All the 
same, upon its low sensitivity for fine changes in hepatic function, clinical reports pronounced serum biliru-
bin levels – even as part of clinical scoring systems - inaccurate for liver functional prediction12,15. Therefore, 
dynamic tests were performed, starting with the clinically most frequently applied liver functional test to date. 
The ICG-clearance test assesses overall liver function, based on the blood disappearance of the fluorescent dye 
ICG, which is exclusively eliminated by the liver without metabolism and enterohepatic recirculation, via a sim-
ilar transport pathway to several exo- and endogenous agents12. Our results indicated a transient reduction in 
global liver function between 24–72 h despite the lack of changes in serum bilirubin levels. Unfortunately, the 
ICG-clearance test is only informative on whole liver function, greatly limiting its applicability. In contrast, the 
nuclear imaging method 99mTc-mebrofenin HBS enables the anatomical localisation of functional data through 
radioactive tracer signal detection from any parts of the body, allowing the differentiation of hepatic uptake and 
excretion, as well the selective measurement of segmental liver function12,13. Clinically, it was found to accu-
rately measure FLR function (close correlation between preoperative- and postoperative scans)25, predict pos-
thepatectomy liver failure26, as well as allow the functional itineration of the second-stage liver resection27–29. For 
these reasons, 99mTc-mebrofenin HBS is a highly relevant method for the quantitative assessment of (regional) 
liver function, currently considered as one of the most accurate and sophisticated over other, previously known 
tests13,28,30. Reports on either experimental or clinical liver functional analysis are available in the settings of 
PH30, PVE10, and the new method associating liver partition with portal vein ligation for staged hepatectomy 
(ALPPS)27–29. However, to our knowledge, no complex or comparative analysis is available on the specific char-
acteristics of liver function utilising the above-mentioned imaging methods regarding LR induced by PVL, even 
though the latter is still widely applied worldwide. Our results concerning global hepatic uptake and excretion 
echoed the ICG-clearance test results, confirming a temporary depression of global liver functions. Interestingly, 
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global uptake normalisation was complete by 168 h, while global excretion recovered only by 336 h. A hypothet-
ical explanation for this lag could be the higher energy consumption of (primarily active) canalicular excretion 
versus (facilitated) basolateral uptake transport parallel to a lower intracellular energy charge. However, its contri-
bution at 168 h is presumably limited when cells are regaining normal energetic levels following the cessation cell 
proliferation18,19. Instead, mechanical factors may play a more significant part, for PVL leads to intraabdominal 
adhesions as well as markedly different anatomical-postural changes of liver lobes, as seen on MRI images, which 
may also interfere with tracer duodenal appearance. In addition, the planar 99mTc-mebrofenin HBS performed 
in the present study also provided quantified information on the individual functional aspects of the LL and the 
NLL. Following an initial reduction in both lobes, we found a progressive divergence of regional hepatic function, 
with the permanent depression of LL and a massive gain in NLL function, resulting in a functional shift towards 
the NLL. In the wake of experienced dramatic changes in NLL function, we embarked to further investigate its 
performance with confocal laser endomicroscopy. CLE is a novel optical imaging method with an endoscopic 
wire probe, primarily designed for non-invasive ‘live optical biopsy’ and improved decision making during clini-
cal endoscopy for gastrointestinal and bronchoalveolar diseases14. From the wide variety of CLE application types, 
a few reports are available regarding the liver31,32. However, to the best of our knowledge, our study is the first 
known experimental application of CLE in the setting of selective probe-measurement of NLL regional function. 
Therein, a transient depression in both uptake- and excretion intensities was observed between 24–72 h, which 
normalised by 168 h, corroborating the results of the 99mTc-mebrofenin HBS concerning NLL function. Regarding 
future concepts, percutaneous realisation of regional liver functional probing by CLE in patient care might have 
great clinical significance, for it could improve or extend the available diagnostics for the chronic or preoperative 
analysis of liver function.
The combined results of all in vivo functional tests imply that recovery of global liver functions is attributa-
ble to the massive functional gain of the NLL, while LL function is permanently deteriorated. Thus, there is an 
apparent discrepancy with in vitro results demonstrating similar functional capacities of cells from the LL and 
NLL. This is most likely stemmed from the fact that in vitro approaches apply standardised conditions of culture, 
nutrition and substrate provision, with no effluent, structural or physiological interfering factors. Additionally, 
selective isolation of viable cells for in vitro methods hinders studying cell death-related alterations. Meanwhile, 
during in vivo experiments, function is measured under (patho)physiological conditions, with dramatic hemo-
dynamic and histological changes. Normally, hepatic endothelial cells are abundantly fenestrated to allow an 
excessive exchange of substances between sinusoids and the space of Disse33. However, PVL leads to the arte-
rialisation of the LL, with respect not only to blood inflow, but also by the partial transition, or ‘pseudocap-
illarisation’ of hepatic sinusoids into standard capillaries, with reduced number of endothelial fenestrations, 
increased perisinusoidal fibrosis, and the development of a basal lamina-like fibroid layer33. Furthermore, 
according to our earlier results15, and current in vivo IF, shrinkage of LL acini along with sinusoidal alterations 
might also lead to blood supply imbalance to LL hepatocytes. Altogether, these changes could substantially 
limit the accessibility to blood-borne macromolecules, such as albumin-bound ICG or 99mTc-mebrofenin, and 
therefore, LL hepatocyte functional output would be limited in vivo, despite a proven retained in vitro function, 
ultimately explaining in vitro and in vivo functional differences. Nevertheless, in sharp contrast, the obvious 
increase in the size of NLL acini could be a feasible reason behind the peculiar gain-of-function of the NLL, 
translating as an increased throughput capacity of bile fluids, bilirubine and other organic anions. Concerning 
these, the other issue needing explanation is the maintained excretion of the endogenous substrate bilirubin, 
whilst excretion of exogenous substrates such as ICG and 99mTc-mebrofenin were temporarily diminished. 
While the exact hepatocyte transport of bilirubin is incompletely elucidated, it is established that bilirubin 
and mebrofenin (and more or less ICG) share, and thus compete for (closely) the same hepatic transport path-
ways13,34,35. Accordingly, both in vitro and clinical reports found reduced mebrofenin transport in hyperbiliru-
binemia34,35. For evolutionary reasons upon its toxicity, it seems plausible, that Oatps may have a higher affinity 
to bilirubin than to mebrofenin, ICG, or other exogenous substrates. Furthermore, increased serum levels 
of inflammatory cytokines, such as TNF-α and IL-6, were reported during LR7, leading to basolateral Oatp 
downregulation, thereby reducing mebrofenin uptake, whereas bilirubin may enter the cell through a different 
pathway or by passive diffusion17,34. These effects may ultimately reason different characteristics of bilirubin 
and mebrofenin transport. Combined, the importance of assertive clinical drug administration is underlined, 
for altered transport functions may lead to changes in drug pharmacokinetics and disposition, potentially 
evoking loss of therapeutic effect or drug intoxication.
In conclusion, our complex analyses of PVL-induced alterations in global and regional hepatic function, con-
firming viable and functional residual cells in the LL, substantially contributes to basic research of LR, holding 
future research and clinical promise regarding reversible PVO. Furthermore, the observed shift of hepatic func-
tion towards the NLL, leading to massive liver functional inhomogeneity underlines, that beyond volumetric 
analysis, liver functional testing is critically important during PVO procedures, for which the novel method CLE 
may prove useful in the future.
Methods
Animals and ethics. Study concept and reporting was in accordance with the Guide for the Care and Use 
of Laboratory Animals prepared by the National Academy of Sciences and published by the National Institutes 
of Health, and the 40/2013 (II.14.) Act of the Hungarian Government, as well as actual ARRIVE Guidelines36. 
The mutual approval of local, as well as institutional ethical boards (Scientific and Ethical Board of Animal 
Experimentation of the National Department of Food-chain Safety; the Animal Welfare Ward of the Food-chain 
Safety, Plant- and Land Protection Division of the Pest County Government Office; and the Animal Welfare 
Committee of the Semmelweis University - license numbers: PEI/001/313-4/2014; PE/EA/2895-6/2016) was 
also granted. Male Wistar rats (Σn = 106) weighing 210–250 g (Central Animal Facility, Semmelweis University, 
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Budapest, Hungary) were allowed 1 week of acclimatisation and kept in an isolated, temperature- and humidi-
ty-controlled room with a 12-hour light-dark cycle and surroundings-enrichment, as well as free access to stand-
ard rat chow and water.
Surgical procedure. Surgical procedures and analytical tests were carried out under general inhalative iso-
flurane anesthesia (Fortec, Cyprane Ltd., Keighley, England; 1–1.5 l/min oxygen containing 2–2.5% isoflurane 
(Vetflurane 1000 mg/g, Virbac, Carros, France). Rats were subjected to PVL corresponding to approximately 80% 
of total liver parenchyma (n = 91) according to the pre-established model of our workgroup15,16. After abdominal 
saline lavage, antibiotic [10 mg/body weight kilograms (bwkg) metronidazole intraperitoneally] and postopera-
tive analgesic (1 mg/bwkg nalbuphine subcutaneously, repeated once 24 h later) administration, a double-layered 
abdominal closure was performed, and animals were rested. Other rats were spared the PVL operation to assess 
preoperative conditions in the three groups utilising time-point termination (n = 3 × 5) (see below).
Experimental setting. For temporal evaluation, rats in all experimental groups were allowed different sur-
vival times declared as (preoperative) control, 24 h, 48 h, 72 h, 168 h, and 336 h, at which experimental analysis 
took place, with optional sacrificing subject to group allocation. Owing to different methods, five experimental 
groups were declared, two of which were used for ICG clearance test (n = 7), as well as for the 99mTc-mebrofenin 
HBS and subsequent magnetic resonance imaging (MRI)-volumetry (n = 9), where the analytical pattern com-
prised a preoperative- and a serial of repeated postoperative scans in the above time points. Three other groups 
were dedicated for the acquisition of blood, bile, and tissue samples (n = 30), CLE data (n = 30), and cell cul-
tures (n = 30). These three groups utilised individual time point termination (n = 5 each) (see Supplementary 
Information, Table 1).
Conventional liver lobe analysis - weight and volume. In two separate groups, the wet weights and 
volumes of the LL and the NLL of the liver were determined gravimetrically (AG 245, Mettler-Toledo LLC, 
Columbus, OH), as well as with serial MRI-volumetry scans (nanoScan PET/MRI; Mediso Ltd., Budapest, 
Hungary), respectively, and expressed as a fraction of body weight (bw) (see Supplementary Information).
Hepatocyte isolation and culturing. For in vitro experiments, hepatocytes were isolated by collagenase 
digestion as previously described37 with a modification of using ‘retrograde’ liver perfusion through the suprahe-
patic inferior vena cava allowing perfusion of both ligated and non-ligated lobes. After collecting cells separately 
from LL and NLL, hepatocytes were seeded onto collagen-coated plates in Williams E Medium containing a series 
of factors for hepatocyte culturing38, and kept in humidified, 5% CO2-enriched atmosphere at 37 °C, receiving 
fresh medium every 24 h. The cultures were overlaid with Matrigel after 24 h (see Supplementary Information).
Immunofluorescence (IF) staining. Liver samples of identical anatomical loci of LL and NLL were 
excised, immediately frozen in liquid nitrogen, and cut by cryomicrotome. Representative cryosections of distinc-
tive time points (control, 72 h as mid-time, and 336 h as end-stage) of LR, as well as isolated hepatocytes 72 h in 
culture from all time points were fixed, permeabilised, blocked, and subjected to primary antibodies against Bsep 
and Ntcp (both antibodies from Bruno Stieger, University Hospital Zürich, Switzerland), Mrp2 (George Scheffer, 
Free University Medical Center, Amsterdam, Netherlands), as well as the tight junction protein ZO-1 (Merck 
Millipore, Billerica, MA). After washes, the samples were stained with fluorophore-conjugated goat anti-rabbit, 
anti-mouse, and anti-rat secondary antibodies (Thermo Fisher, Waltham, MA), as well as with DAPI for nuclear 
staining. The blue, green, and red fluorescence images of stained hepatocytes and liver sections were acquired by 
wide-field and confocal microscopy (Leica, Wetzlar, Germany), respectively. As negative controls, samples sub-
jected to no primary antibodies were used (see Supplementary Figure 6). Images were analysed by ImageJ 1.51 h 
(National Institutes of Health, Bethesda, MD) (see Supplementary Information).
In vitro taurocholate- and bilirubin transport analysis. Bilirubin and taurocholate transport exper-
iments were performed 72 h after culturing, when functional bile canaliculi were formed between adjacent 
cells, as described previously38,39. For bilirubin transport analysis, cells were provided 10 μM bilirubin in Hank’s 
balanced salt solution (HBSS) for 5 min, followed by washing and an efflux period in either standard or Ca2+/
Mg2+-free HBSS for 10 min. Then the cells were lysed with an acetonitrile/water solution. The bilirubin and 
its mono- and diglucuronide conjugate content of both the efflux media and the cell-lysate were determined 
by high-performance liquid chromatography (HPLC). From these results, basolateral uptake, canalicular- and 
sinusoidal efflux transport rates, as well as intracellular accumulation of bilirubin were calculated. The experi-
mental procedure for TC transport analysis was similar to that of the bilirubin transport, while applying 3H-TC 
as substrate at 1 μM for 1 min. The efflux lasted for 10 min, and the cells were lysed with 0.5% Triton X-100 in 
phosphate-buffered saline. TC content of the efflux media and the lysates were determined by liquid scintillation 
counting (see Supplementary Information).
In vivo assessment of bile excretion. Serum and bile samples were collected in the tissue harvest group. 
After median laparotomy, selective biliary drainage of the LL and NLL was realised with the insertion and 
glue-fixation of 1.8 F polyethylene cannulas (PE10, Harvard Apparatus, Holliston, MA) into anatomically corre-
sponding bile ducts (see Supplementary Figure 4)15. The amount of bile produced by the LL and NLL over 40 min 
was measured gravimetrically and expressed as a fraction of bw. Furthermore, citrate-anticoagulated serum samples 
were prepared with routine laboratory techniques from the blood acquired during exsanguination. The amounts 
of UCB and BG were determined by HPLC from both bile and serum samples (see Supplementary Information).
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Indocyanine-green clearance test. The ICG-clearance test was performed as described previously15 with 
the modification of ICG injected through the lateral tail vein for repeatability. Results were displayed as PDR and 
RT15 values (see Supplementary Information).
Planar 99mTc-mebrofenin hepatobiliary scintigraphy. After the intravenous injection of 150 MBq 
99mTc-mebrofenin [combination of Bromo-Biliaron (Medi-Radiopharma Ltd., Budapest, Hungary) and 99mTc 
isotopes (Ultra-Technekow Technetium Generator, Mallinckrodt Medical, Petten, Netherlands)], planar HBS 
was acquired using an ultrahigh resolution collimator (NanoSPECT/CT Silver Upgrade and NanoSPECT-UHR, 
Mediso Ltd., Budapest, Hungary) in three dynamic phases of 20/6/2 frames per minutes for 2/4/35 minutes, 
respectively. By allocation of regions of interests (ROI) to the blood pool, LL, NLL, and the duodenum, tracer 
B1/2, DSTART, and the relative ratio of LL or NLL PCs to corresponding blood counts were determined (see 
Supplementary Information).
Confocal laser endomicroscopy. Following laparotomy, the endoscopic wire probe of the laser unit 
(Cellvizio, MaunaKea Technologies, Paris, France) was motionlessly fixed to the (stabilised) inferior right lateral 
lobe of the NLL. After the intravenous injection of 1.5 mg/bwkg ICG in distilled water, a 40-minute time lapse 
video was acquired, allowing ROI allocation to liver acini and subsequent determination of TMAX and ICG T1/2 
values (see Supplementary Information).
Statistical analysis. Data was expressed as mean ± standard deviation. For parametric data analysis of var-
iance with Bonferroni’s post hoc test was performed. Pearson’s correlation test was used to correlate parametric 
data. P-values of less than 0.05 were considered statistically significant. Calculations and visualisation were per-
formed with GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA) and Origin (OriginLab Corporation, 
Northampton, MA).
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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